News / Science News |
New study identifies gene variant linked to compulsive drinking
NIH | JULY 22, 2015
Carrying a gene variant that affects the release of a specific brain protein may put one at greater risk of developing an alcohol use disorder, according to the results of a recent animal study.
Scientists found that mice carrying the Met68BDNF gene variant, which reduces the release of brain-derived neurotrophic (BDNF) factor, would consume excessive amounts of alcohol, despite negative consequences. BDNF plays a role in the survival of existing neurons and the growth of new neurons and synapses, the junctures through which cell-to-cell communication occurs.
The human form of this gene variant, Met66BDNF, leads to a reduction in the normal function of BDNF in the brain and is associated with several psychiatric disorders, including schizophrenia and depression.
Significantly, researchers were able to reverse compulsive alcohol drinking in the mice using gene delivery and pharmacology. Increasing levels of BDNF in the ventromedial portion of the prefrontal cortex, a brain region involved in compulsive drug and alcohol seeking, returned the mice to moderate levels of alcohol intake.
In addition, by administering a pharmaceutical compound developed to mimic the action of BDNF, researchers were also able to put a stop to compulsive drinking behaviors. This compound (LM22A-4) may have potential as a therapeutic for humans. It appears to reduce compulsive alcohol drinking without a generalized effect on motivation.